Cite

HARVARD Citation

    Packnett, E. et al. (2022). RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020. Human vaccines & immunotherapeutics. 18 (6), p. . [Online]. 
  
Back to record